Podcasts about chief science officer

Free course: Improve your metabolic healthGet our free email course on how glucose, nutrition, exercise, sleep, and measurement can help you build habits that support better energy and long-term health: ⁠⁠⁠https://levels.link/wnl⁠High cholesterol. Elevated ApoB. A positive CAC score. Now what?Most people quickly find themselves trapped between two extremes: simplistic advice to “cut saturated fat” and online influencers insisting cholesterol doesn't matter at all.In this episode of A Whole New Level, Mike Haney sits down with clinical research scientist Dr. Kevin Maki to cut through the confusion.Drawing on more than 35 years of cardiovascular research, Maki explains why heart disease risk is about much more than LDL cholesterol alone. He breaks down the roles of inflammation, blood sugar, family history, kidney function, and lipoproteins, while also making a clear case for something many people resist: LDL and ApoB still matter. A lot.The evidence increasingly suggests that when it comes to atherosclerosis, lower for longer is better. That has important implications for diet, statins, and how early we should intervene.Mike and Dr. Maki also tackle saturated fat, seed oils, red meat, industry-funded research, and how to separate evidence from online nutrition debates.

● Dr. Pat Ivey is the Associate Athletic Director for Student-Athlete Health and Performance at University of Louisville and currently serves as President of the Collegiate Strength and Conditioning Coaches Association Board of Directors. With more than 20 years of experience in collegiate athletics, he has held leadership roles at Louisville, Missouri, and Arkansas State while becoming one of the most respected voices in athletic performance and leadership.● Jason Wilfawn is the Director of Strength and Conditioning for the Oxford School District and the 2024 Mississippi High School Strength & Conditioning Coach of the Year. With more than 20 years of experience in athletic performance, he has worked across the high school, private sector, and Division I collegiate levels, including stops at the University of Mississippi, the University of Arkansas, and the University of Evansville● Aaron Duvall is the Assistant Athletic Director for Sports Performance at University of Pittsburgh, where he oversees all strength and conditioning and applied sport science operations for the athletic department. In addition to leading Pitt's integrated high-performance model, he directly oversees the training of the women's volleyball program.● Beth Byron is the Chief Science Officer for the Collegiate Strength and Conditioning Coaches Association, where she helps guide the organization's scientific and educational initiatives. With nearly two decades of experience in collegiate athletics, she has held strength and conditioning positions at West Virginia University, University of South Florida, The Ohio State University, and The University of Texas at Austin. Matt Jennings is the Assistant Athletics Director for Strength and Conditioning at XavierUniversity, where he oversees strength and conditioning for all 19 varsity athletic programs. A member of the Xavier staff since 2007, Jennings was promoted to his current leadership role in 2021 after helping build and advance the department's performance culture.

Primary stroke prevention is a critical opportunity for neurologists, with most stroke risk driven by modifiable factors such as hypertension and lifestyle behaviors. This episode highlights practical tools and strategies, including Life's Essential 8 and contemporary risk calculators, while also exploring evolving approaches to shared decision making and secondary prevention. In this episode, Katie Grouse, MD, FAAN, speaks with Mitchell S. Elkind, MD, MS, FAAN, author of the article "Stroke Prevention" in the Continuum® June 2026 Cerebrovascular Disease issue. Dr. Grouse is a Continuum® Audio interviewer and a clinical assistant professor at the University of California, San Francisco in San Francisco, California. Dr. Elkind is the Chief Science Officer for Brain Health and Stroke at the American Heart Association in Dallas, Texas, and a professor of neurology and epidemiology at Columbia University in New York, New York. Additional Resources Read the article: Stroke Prevention Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Guest: @MitchElkind Full episode transcript available here Dr Grouse: Neurologists have generally been more involved in secondary stroke prevention, but primary stroke prevention is increasingly recognized as an important topic of discussion for neurologists. Today, I have the opportunity to interview Dr. Mitchell Elkind, who wrote the article on stroke prevention in the newest Continuum issue on cerebrovascular disease.  Dr Jones: This is Dr. Lyell Jones, Editor-in-Chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME, subscribing to the journal, and exclusive access to interviews not featured on the podcast.  Dr Grouse: This is Dr. Katie Grouse. Today, I'm interviewing Dr. Mitchell Elkind about his article on stroke prevention. This article appears in the June 2026 Continuum issue on cerebrovascular disease. Welcome to the podcast, and please introduce yourself to the audience.  Dr Elkind: Thank you so much, Katie. So, my name is Mitch Elkind, and I'm the Chief Science Officer for Brain Health and Stroke at the American Heart Association and a stroke neurologist by background.  Dr Grouse: Well, I just want to start by saying that I really enjoyed reading this article. I think this is just a really wonderful article I recommend strongly. Such a high yield, an important topic for a lot of us who see patients who are interested in learning about their stroke risks or need help with, uh, stroke prevention after having a stroke. So, I wanted to start. What's changed in the last couple of years? You know, what are some big highlights that you really want to stress that are different from maybe the last time we reviewed this topic?  Dr Elkind: Sure. Well, there's been a lot of development in the field of secondary stroke prevention, for one thing. But even beyond that, I think we increasingly appreciate how important it is to control what we call the social drivers of health on the earlier side, primordial or primary prevention. And that has been a big advance, I'd say. And I would also say, I think it's really important for neurologists to understand some of those questions about primordial and primary prevention. You know, we tend to get involved with patients after they've had a stroke or maybe a TIA, some kind of event. But sometimes we find people who are following for, you know, non-stroke related conditions who have risk factors also. And we can really play an important role in identifying those risk factors and helping to prevent a first stroke or vascular event as well. So, I think it's real important for us to be doctors even before we're neurologists. So, you know, Katie, about ninety percent of stroke risk is modifiable, so we can do a great job as neurologists in preventing stroke. And one of the most important things that we can do is to identify and treat high blood pressure. And recently, actually, the American Heart Association, American College of Cardiology guidelines on the management of hypertension have said that treatment of high blood pressure not only prevents stroke, but it can also help to prevent cognitive decline and dementia. And this is the first time that we've had a class of recommendation one and level of evidence A, the highest level of recommendation we give for the use of blood pressure treatment to prevent dementia. And that's largely based on the results of some large trials that have come out recently showing that you can prevent dementia with blood pressure control. So that's a really exciting link, I think, between cardiovascular risk factor control and subsequent brain health. It just illustrates the role that neurologists can play in, so many conditions outside of stroke as well.  Dr Grouse: That's a really great point, and I want to get a little more into the idea of primordial stroke prevention. Can you tell us a little bit more about what that might be?  Dr Elkind: So primordial prevention refers to addressing how we can prevent risk factors from occurring in the first place, and how can we improve the environments in which people live. You know, we know that only about twenty percent of health outcomes is dependent on what happens between the patient and their doctor in the office. About eighty percent of it is due to what happens in the environments in which we live, work, pray, and play. And so that's what we mean when we refer to the social drivers of health. What is the neighborhood like where somebody lives? Do they have access to healthy food? Do they have places where they can go to exercise? Is there air pollution in the area that may affect their health? You know, one really interesting fact that's become apparent in the last few years is that air pollution is a major risk factor for stroke. Something like a sixth of all strokes can be attributed to the quality of air. And so, what are the things we can do at the broader public policy, community level to reduce the risk of risk factors like high blood pressure and diabetes even before somebody has an event that brings them to the attention of the doctor? So that's what we're thinking about with regard to primordial prevention. It's the earliest stage in prevention.  Dr Grouse: And that's really fascinating. You know, I think an area that we haven't, as neurologists, really put a lot of our time thinking about, but clearly a very important thing. I really appreciated reading your article about how you incorporated the fact that, you know, a lot of these risk factors overlap very, very closely with all the risk factors for various types of cardiovascular events. And I would imagine that the work you've done as the Chief Clinical Science Officer for the American Heart Association has informed a lot of the way you've thought about-Trying to bring all these risks together and think a little bit more holistically about the whole thing. Could you tell us a little bit more about that and the work that you've done on the American Heart Association's Life's Essential 8 score?  Dr Elkind: Sure. I can't take credit for it. It's really work that was done by others at the Heart Association, particularly a cardiologist and epidemiologist named Don Lloyd-Jones. But many other volunteers participated. Life's Essential 8 is our approach to primary stroke prevention and cardiovascular prevention more broadly. We say Life's Essential 8 because it includes four health behaviors and four health factors that people can observe to reduce their risk of cardiovascular disease. The four factors are kind of things like know your numbers, your blood pressure, your blood sugar, your body mass index, right, which is a combination of weight and height, and your cholesterol level. So, know those numbers and keep them within the recommended ranges, and talk to your doctor if they're not. And then four lifestyle behaviors. So, one of them is to eat a healthy diet, and typically that means the Mediterranean diet. It means getting regular exercise, and we recommend 150 minutes a week of moderate to vigorous physical activity. Of course, it means abstinence from smoking or other tobacco products. And the last one, the eighth one, which I was so excited about when we added this, is sleep, recommending at least seven hours of sleep a night. So, I was really excited about this because we used to talk about Life's Simple 7, and then the last iteration of our recommendations included this recommendation for adequate sleep because of the mounting evidence of the importance of sleep to cardiovascular health. But sleep is really a brain function, right? And so, it was really the first, in a way, specific brain function that was added to our recommendations. So that's Life's Essential 8. People can read about it online at heart.org and recommend it to your patients as a simple way for people to understand the best approach to reducing their risk of cardiovascular disease, including stroke.  Dr Grouse: I checked it out myself after reading the article. It's very accessible to patients. It's a great education tool. And they can, you know, see their own score and use that in their own way to, to think about what their risks are and how they can help mitigate and then rescore themselves down the line. There's also, though, on the kind of more the clinician side, the PREVENT calculator as well. Could you tell us a little bit more about how we could use that in approaching this patient population?  Dr Elkind: Yeah. So, I think of Life's Essential 8 as being a patient-focused tool that people can use. PREVENT is really more for clinicians. Anybody can look it up online and enter your data into it. There's a risk calculator online. But the basic idea behind PREVENT and other similar risk calculators is that it's a way to estimate somebody's risk of having a cardiovascular event like stroke or a heart attack or even heart failure by entering information about your health. And we used to think, we used to use something called the ASCVD, atherosclerotic cardiovascular disease risk calculator, or the Framingham score. Framingham Heart Score, for example, was another one. PREVENT is the latest version, and it has several advantages over those earlier types of risk predictors. For one thing, it predicts risk at younger ages as well. It goes down to age 30. It predicts risk over a longer duration of time, so over 30, 10 or 30 years. It eliminates the use of race as an item to put into the calculator and substitutes for that socioeconomic status, so it's not a race base, but a measure of social disadvantage. And it also includes kidney elements, kidney measures. It includes renal function, for example, that weren't included in prior measures, and it can also be used to predict heart failure, which was not part of the original calculators. Another major advantage of the PREVENT study is that it was based on real-world data from about three million patients, many, many more than the 50,000 or so that the earlier risk calculators were based on. So, it has a much more robust data set and therefore allows a bit more precision in the ability to predict future risk of events. And typically, primary care doctors would enter their patient's data, calculate a risk, and then based on the results of the risk calculator, they can make recommendations about what type of medications a person should take or what other strategies they could use to reduce their risk. And so that's the role that PREVENT plays, is really being focused more for the clinician than the patient.  Dr Grouse: Really great tool for us to be aware of. You earlier alluded to the fact that neurologists are in the situation where we sometimes are helping patients with this primary prevention. But you also make a case for why it's in the patient's best interest for us to be involved in, in these conversations when we can, when we have the opportunity. Can you tell us more about that?  Dr Elkind: Shared decision-making is really important because we know that people aren't going to lead the healthiest possible lives if they're not invested in their care. And so, a doctor telling somebody what to do if the patient doesn't want to do it is gonna have limited benefit.So we emphasize the importance of shared decision-making as much as possible. And I think that where this comes up a lot is actually in the situation of, for example, atrial fibrillation, where patients will often be put on a blood thinner. And many people are fearful of blood thinners. They worry about the risk of bleeding. Maybe they know a relative who's had a bleeding complication from a blood thinner, and so they may be disinclined to try it. And so, it's really important to have these discussions about the risks and the benefits of medication and engage the patient in thinking about this. And there are even tools and visual aids that people can look to to help explain some of these complicated concepts to patients. So, these are the kinds of things that reflect implementation science as a way to improve adherence. We know what works in a clinical trial setting often, but the challenge is translating that into the real world and getting our patients to use the medications that we believe scientifically have been shown to be of benefit. I've actually been surprised sometimes at conversations I've had with people, in some cases, healthcare professionals who resist going on blood thinners because of their fear of the complications. And I feel like the evidence is there. Why don't they believe me? And that's why it's really important to have the conversation. Even our peers and colleagues can sometimes question the evidence, and it's important for us to be aware of that.  Dr Grouse: Absolutely. I think that sounds very reasonable to me, and hopefully these tools will help us with making some of these decisions with our patients. Now, turning our attention a little bit to secondary prevention. So, you know, someone's already had a stroke or a TIA, sort of thinking about what we can do to optimize their risk factors for further strokes. You know, I think there has been some changes that have happened, I think, in the last few years that might be affecting some of the decisions we're making and some of the advice we're giving our patients. I wanted to talk a little bit about GLP-1 receptor agonist medications. Is the data there to support use of this either in secondary prevention or even in primary prevention in the case of stroke?  Dr Elkind: There is evidence that supports the use of GLP-1s for stroke prevention. We need more data, though. We need trials that focus only on patients with stroke, for example, there have been studies in patients with cardiovascular disease broadly that include stroke patients. But if you look at the subcategory just of stroke patients alone, the data in that subgroup alone don't always show a benefit. And so, we need more data that's focused on stroke patients alone. So, I think the data are continuing to emerge, but we need more still.  Dr Grouse: Is there any development in the thought about whether we should be putting patients on antiplatelet therapies for incidental, incidentally identified strokes? For instance, if you got an MRI for migraine or for other reasons and you found one, no history of any stroke-like symptoms. Should we be putting these patients on aspirin or any other types of therapies?  Dr Elkind: That's a really great question. And again, it's an area where there's some controversy and really, there's really no definitive data that would support using antiplatelet therapy in people with incidentally discovered infarcts or what we call, you know, whispering strokes or silent strokes. Many stroke neurologists will use antiplatelet agents. This is one of those areas where it's so important to identify the risk factors. As we were saying before, patients who have other neurological disorders like migraine or epilepsy may turn out to have cardiovascular risk factors like diabetes and high blood pressure. That's why it's so important for neurologists to be able to treat those patients or refer them to specialists who can. Patients who have incidentally discovered lesions similarly are a group where we should be looking for risk factors. So, I don't think of it only in terms of do we put them on an antiplatelet or not, but really more holistically, can we identify their other risk factors and address those? Should the patient's information be entered into a risk calculator like PREVENT, for example, so that we can come up with a more global or holistic measure of their cardiovascular risk and address that as appropriate? Because if they are at risk for stroke, they're also at risk for cardiac events, including heart attack, heart failure, sudden cardiac arrest, and so forth. So, I think of it as a, as a great kind of teachable moment or an opportunity to catch somebody and bring them into the healthcare system more broadly and address those other potential risk factors.  Dr Grouse: Speaking of, of risk factors that we often like to think about and work up when possible, in cases where it seems certainly possible the patient had an embolic stroke, but perhaps we've done a few weeks or four weeks of cardiac monitoring, have not found any evidence of atrial fibrillation. What's new and what's the current recommendations for doing further monitoring when there's high suspicion for cardioembolic stroke?  Dr Elkind: This is a really active area of investigation, and guidelines suggest that we should do some cardiac monitoring for atrial fibrillation after an unexplained stroke, but it's not clear how much we should do. Studies generally show that the longer you follow somebody on a cardiac monitor after stroke, the more likely you are to detect atrial fibrillation. It could be as high as thirty percent after a few years. And that's great. And if you detect atrial fibrillation, people usually end up being recommended for a blood thinner. But how extensively we should monitor remains unknown. And I think a lot of the investigation recently has been around the question of, are there other ways to get that information rather than waiting six months or a year for the person to develop atrial fibrillation?It's a little bit funny logically to think a person has a stroke today, a year later you discover atrial fibrillation on the monitor, and you say, "Oh, now I know what caused your stroke a year ago." Right? The temporality, the causality perhaps is off in that case. And so, wouldn't it be better if we could tell what somebody's risk of having another cardioembolic stroke is, or the likelihood that they have atrial fibrillation is at the time that you first see them for the stroke, you know, in the hospital, for example. And so, there's some really new technologies that have evolved like AI or artificial intelligence interpretation of EKGs that can give a really good indication of which people are gonna go on to develop atrial fibrillation. And so, I think we need some more trials in that area to demonstrate that we can detect the risk of AFib and treat that even before it appears on one of those delayed monitors. That's an area that I think is very exciting right now. There's also a further question with regard to how to treat these patients, which is that sometimes atrial fibrillation is a consequence of the stroke itself. So, we can think about what people call known AF, meaning atrial fibrillation that's known about before the stroke even occurs, versus AF that's detected after a stroke, or AF-DAS, people will say. Those may have very different implications for the risk of recurrence and what the person's cardiovascular status is. So, I think what we've learned over the last few years is that atrial fibrillation, it used to be like the slam dunk for a stroke neurologist. It was the easy thing. You know, you had a stroke, you have AFib, you should be on a blood thinner. Now we know that there's lots of different kinds of AFib. There's AFib before stroke, there's AFib after stroke, there's burden of atrial fibrillation. So, some people may have 30 seconds of AFib, some people may have several hours, some people may be in it continuously. It comes and goes, and that can make it challenging to manage. So, we have a lot more work to do to understand this problem better.  Dr Grouse: That also gets me into some other interesting areas that I think there's still some question, you know, how aggressive should you be? How often is it a case of is this correlated or is this causative? For instance, when a patent foramen ovale is, is discovered in patients with cryptogenic stroke. Are there any tools or new developments to help us understand whether these PFOs should be closed in these cases?  Dr Elkind: PFO and stroke is a great story that's been going on for decades. And again, we've made tremendous progress in the last several years. So, it's true that about 20% or so of people have a PFO, and because of that, it can be really hard to say with any certainty whether an individual patient sitting in front of you, that the PFO was the cause of their stroke. Rarely we can have a really high degree of certainty. You know, if somebody has, uh, a DVT, for example, and shortly after that maybe they have pulmonary embolism and then a stroke, and we can say, "Oh, clearly this was a paradoxical embolism," went to the lungs and then some crossed over and went to the brain. That happens really infrequently. Most of the time you're faced with a patient who has a PFO and a stroke, and they may have some other risk factors. There are some tools that we can use to help figure out the likelihood that a PFO is related to a stroke. One of those is called the ROPE score or the risk of paradoxical embolism score that was developed by David Thaler and, uh, David Kent from Tufts and a group of other investigators as well. That score allows one to say what the likelihood is that the PFO was causative of the stroke, and it's based on a person's risk factors such that the younger you are, the more likely it is the PFO caused the stroke. And the absence of risk factors make it more likely that the PFO caused the stroke. So, the higher your ROPE score indicating the fewer other reasons you have a stroke, the more likely the PFO is to be causative. So that can be helpful in identifying patients who may have had a stroke due to their PFO. There are other features that are identified in something called the PASCAL score, which is a way of assessing the degree of shunting and whether or not there's an atrial septal aneurysm that can be used as additional factors that lead to the likelihood that a PFO was causative rather than just incidental. So, by putting this kind of information together, we can kind of do precision neurology or precision prevention by identifying which patients with a PFO are really the ones we need to worry about and do procedures like closure.  Dr Grouse: I look forward to hearing more and learning more as more advances are made in these areas. Dr Elkind: Thank you.   Dr Grouse: And thank you so much for joining us today to talk about your article.   Dr Elkind: Oh, I appreciate it. Thank you for giving me the opportunity. I really enjoyed it.  Dr Grouse: Again, today I've been interviewing Dr. Mitchell Elkind about his article on stroke prevention. This article appears in the June 2026 Continuum issue on cerebrovascular disease. Be sure to check out Continuum Audio episodes from this and other issues, and thank you to our listeners for joining today.  Dr Monteith: This is Dr. Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.

"Sustainable aquaculture needs to be part of the solution set for health, for feeding a growing population, and it increasingly can be done well, that's the thing. There's been a lot of innovation in that field over the last few decades….There are different types of aquaculture. So the gold standard, if you're offered an oyster or a mussel or a clam, you can always feel good about those choices because they are a net benefit to the planet…What I think is important is a lot of chefs and a lot of startup aquaculture companies are getting in the game and looking to make the industry more and more sustainable, which is better for all of us going out to restaurants." Amanda Leland on Electric Ladies Podcast  Do you eat fish and seafood? Over 3 billion people depend on fish for their protein (like me) and that number is growing. Over 60 million people are employed by the fishing and acquaculture industries. But pressures from climate change, plastic pollution and overfishing are threats. What can we do to save our fish and seafood?   Listen to Amanda Leland, Executive Director of the Environmental Defense Fund (EDF) and the author of the new book, "Sea Change: Unlikely Allies and a Success Story of Oceanic Proportions," in conversation with Electric Ladies Podcast host Joan Michelson   You'll hear about:   ·       What sustainable fish and seafood is and why it matters ·       What overfishing is, why it matters and what to do about it ·       How plastic in the oceans is affecting our fish and seafood ·       What legal strategies EDF is employing to try to clean up and protect our fish and seafood, ·       Plus, insightful career advice.   "I think this is an undervalued thing, always hire people better than yourself…It gives you more scope to grow, I think if you hire people better than you into the roles that report to you. So that's one thing I think is a secret of success….Somebody who's doing things better, more efficiently on your team than you did them, even though it might feel like you're going to read it as a reflection that you didn't get it quite right, you actually end up getting rewarded because that person is doing the job better and it's under your oversight and management support…. disconnect from the personal so much and make it actually, when my unit is successful or my team is successful, then I'm successful." Amanda Leland on Electric Ladies Podcast Subscribe to our newsletter to receive our podcasts, articles, events and career advice – and special coaching offers.   Thanks for subscribing on Apple Podcasts, iHeart Radio and Spotify and leaving us a review!   You'll also like:   ·       Food, Fashion and Agriculture in Climate Change - From The Earth Day Women's Summit ·       What's in Your Food? - with Gabrielle Rubenstein, Cofounder, Managing Partner, Manna Tree Partners ·       How Stories Can Shift Culture and Policy - with Melissa Jun Rowley, Author of "Beyond the Mic Drop: How Stories Can Shift Culture, Power & Policy" ·       Zara Summers, Chief Science Officer at LanzaTech, on how carbon emissions are converted into sustainable materials for clothing, food, and fuel. ·       And, insightful career advice…  Elevate your career with expert coaching and ESG advisory with Electric Ladies Podcast. Unlock new opportunities, gain confidence, and achieve your career goals with the right guidance.   Don't forget to follow us on our socials X/Twitter: @joanmichelson LinkedIn: Electric Ladies Podcast with Joan Michelson Twitter: @joanmichelson Facebook: Electric Ladies Podcast YouTube: Electric Ladies Podcast

This conversation with Dr. Michael Mantell focused on the connection between mental health, resilience, and overall well-being. Dr. Mantell shared insights on the importance of developing a positive mindset, managing stress effectively, and building healthy habits that support both emotional and physical health. He emphasized that personal growth begins with self-awareness and intentional choices, and that resilience can be strengthened through practice and perseverance. The discussion highlighted practical strategies for maintaining balance, overcoming challenges, and living a more fulfilling and purposeful life. Dr.Michael Mantell Biography Dr. Michael Mantell, a Renowned and Esteemed Mental Health Architect, earned his Ph.D. from the University of Pennsylvania in 1976 and his MS in Clinical Psychology in 1972 from Hahnemann Medical College. He guides clients to disturb themselves less, by identifying, challenging, and restructuring irrational beliefs, helping them build a reliable foundation of rational, flexible thinking, and adopt healthier behaviors and attitudes. His expertise bridges the art and science of mental health, empowering clients to disturb themselves less and construct a mindset that enables them to respond to life’s challenges with resilience, acceptance, and self-compassion. Throughout his career, Dr. Mantell has held various prestigious positions, including Chief Psychologist for Children's Hospital of San Diego, Chief Psychologist of the San Diego Police Department, and Chief Behavior Science Consultant for the American Council on Exercise. He was a co-founder and Chief Science Officer of Plus Size Certified, Inc. and is a member of the Science Advisory Council of the International Council on Active Aging. In addition, he served as Assistant Clinical Professor in the Department of Psychiatry at UCSD Medical School, where he taught the Doctor-Patient Relationship course. He brings a specialty focus on physician wellbeing, physician burnout and elevating the patient experience. He has lectured at Pt. Loma Nazarene University and has provided a yearly 3-day Physician Wellness Studio for the American Society of Hematology. He is an invited guest instructor at Harvard University. Dr. Mantell is a prolific author with four books to his name, including his recent work, "The Link is What You Think," "Ticking Bombs: Defusing Violence in the Workplace," and his iconic 1988 original "Don’t Sweat the Small Stuff PS: It’s All Small Stuff" and its 25th Anniversary Edition. Dr Mantell has been a member of SAG-AFTRA since 1981, Chair of its Election Committee and Vice-Chair of the Government Affairs and Public Policy Committee. He was elected to the Board of SAG-AFTRA San Diego in September, 2025. He’s been bringing psychology to the broadcast media for decades including regular appearances on Good Morning, America, Oprah Winfrey and weekly spots on local and nationwide news. You can follow his free daily “MantellPoints2Ponder” on LinkedIn and Facebook.Support the show: http://www.cooleyfoundation.org/See omnystudio.com/listener for privacy information.

Full show notes: https://bengreenfieldlife.com/marapodcast In this episode, you will hear the origin story of Mara Labs, a company built around sulforaphane, the active compound found in broccoli that has been studied across thousands of papers covering almost every major chronic disease, and why most people are not actually getting it from their broccoli supplements. You will discover why the way your broccoli supplement is made determines whether any of it reaches your cells at all, what dose of the active compound moves the needle on inflammation, detox, and cellular defense, and how a single capsule compares to eating five pounds of adult broccoli a day. You will also hear something that has not been discussed publicly before: a pilot study showing that this same compound can trigger your cells to release microplastics, those synthetic particles now found in human blood, lungs, and breast tissue, and push them out through your digestive system. David Roberts is the co-founder and managing partner of Mara Labs. After his wife Mara was diagnosed with breast cancer in 2012 and passed away in 2017, David channeled his experience into building a supplement company grounded in clinical science rather than ingredient trends. Dr. John Gildea is Chief Science Officer and co-founder, with a PhD in molecular biology and over 20 years studying the Nrf2 pathway at the University of Virginia. Author of more than 60 peer-reviewed publications, he developed the stabilization method that made shelf-stable sulforaphane possible and has since led research on sulforaphane's effects on microplastics and cancer stem cells. For the next week, save 25% off all Mara Labs products using code BEN at bengreenfieldlife.com/maralabs. After June 20th, the code returns to the standard 15% off. Episode Sponsors: Fatty15: Fatty15 is on a mission to optimize your C15:0 levels and help you live healthier, longer. You can get an additional 15% off their 90-day subscription Starter Kit by going to fatty15.com/BEN and using code BEN at checkout. Hiya: Give your kids the full-body nourishment they need to grow into healthy adults. I’ve secured a special deal with Hiya on their best-selling children's vitamin—get 50% off your first order today! To claim this deal, you must go to hiyahealth.com/BEN (it is not available on their regular website). Young Goose: To experience the transformative power of Young Goose's cutting-edge skincare products, visit younggoose.com and use code BGF10 at checkout to enjoy a 10% discount on your order. Quantum Upgrade: Recent research has revealed that the Quantum Upgrade was able to increase ATP production by a jaw-dropping 20–25% in human cells. Unlock a 15-day free trial with the code BEN15 at quantumupgrade.io. Pendulum: Metabolic Daily is a powerful multi-strain probiotic that improves your metabolism, reduces sugar cravings, breaks down carbs more efficiently, and sustains your energy levels. You’ll receive 20% off your first month of any Pendulum probiotic with code BEN at PendulumLife.com.See omnystudio.com/listener for privacy information.

Welcome to this special edition of the financial crime weekly podcast.If you've been paying attention to the news this week, or at any time in the last two years, you can't have failed to notice the cybersecurity landscape has officially crossed a terrifying new threshold. Google's Threat Intelligence Group released a report confirming that generative AI has moved from a shiny new toy to a routine weapon for cybercriminals and nation-state actors.For the very first time, researchers caught hackers using artificial intelligence to discover and weaponise a zero-day exploit, successfully bypassing two-factor authentication in a mass exploitation attempt. With AI-driven bot attacks surging from 2 million to a staggering 25 million incidents globally over the last year, the reality is clear: the bad guys are using AI to scale their attacks faster than humanly possible.So, how do we fight back? We have to fight fire with fire.To help us understand how the good guys are weaponising AI for defence, I'm thrilled to welcome Pedro Bizarro to the show. Pedro is the Co-Founder and Chief Science Officer at Feedzai, a global leader in AI-driven fraud prevention and financial risk management. A true pioneer in the space, Pedro transitioned from a decade-long research career, armed with a Computer Science PhD from the University of Wisconsin-Madison, to building out Feedzai's industry-leading RiskOps platform. He holds over 90 patent applications and has authored more than 100 scientific publications. Pedro, it is a critical time for this conversation….

The job of scientists is a tough one - to take complex, multifaceted, messy concepts, and do their best to simplify them in a way that is understandable and digestible to the general public. However, today's guest, Dr. Lisa Feldman Barrett,  warns that if something is too simple, we probably shouldn't believe it.  Especially when it comes to human behavior and emotions, there's nothing simple about it - because variation is the norm - not averages.  And in today's episode, Dr. Barrett explains exactly why that is and how it should change the way we view and approach our interactions. Dr. Barrett is among the top 1% most cited scientists in the world for her revolutionary research in psychology and neuroscience. She is a University Distinguished Professor of Psychology at Northeastern University, and she holds appointments at Harvard Medical School and Massachusetts General Hospital, where she serves as Chief Science Officer for the Center of Law, Brain and Behavior. In addition to the books 7 ½ Lessons About the Brain and How Emotions Are Made, Dr. Barrett has published over 260 peer reviewed scientific papers. Not only do we dive into the scientific research that disproves the way many of us have been led to view emotions, Dr. Barrett also does a phenomenal job of speaking to these concepts in a way that helps us apply it to our daily lives. Specifically, we address “The Great Man Theory” - why there is no one-size fits all approach to emotions and what they mean How understanding emotional constructs on a deeper level can make people more adept at navigating social situations The physiological and psychological processes of how we give meaning to our emotions Specific instances where knowing this information can directly influence life outcomes for you and those you impact daily Referenced Resources: Website: Lisafeldmanbarrett.com Book: How Emotions Are Made Book:  7 ½ Lessons About the Brain  TED Talk: You Aren't At the Mercy of Your Emotions Research Article: Knowing what you're feeling and knowing what to do about it   Resources & Links: Art of Coaching for coaching programs and resources: https://artofcoaching.com/mentoring My Latest Book (Link to upcoming or referenced publication): https://amzn.to/4rZknhs Connect with Brett Bartholomew: LinkedIn Twitter   Follow Us: Website: ArtofCoaching.com Instagram: @coach_brettb X: @coach_brettb

Sleep impacts every aspect of our health—from athletic performance and recovery to hormone balance, cognitive function, and longevity. But one of the most overlooked factors affecting sleep quality may be something surprisingly simple: temperature. In this episode of Marni On The Move, I speak with Dr. Nicole Moyen, Chief Science Officer at Eight Sleep, about the science behind better sleep and how temperature regulation can help optimize health, performance, and overall well-being. We dive into the role temperature plays throughout the sleep cycle, how sleep needs change with age, the impact of hormones and menopause on sleep quality, and how personalized sleep technology is helping people better understand and improve their rest. Dr. Moyen also shares practical strategies for athletes, insights into sleep stages, heart rate variability (HRV), chronotypes, and the future of sleep science. Whether you’re an athlete looking to recover faster, navigating midlife sleep changes, or simply looking to wake up feeling more energized, this conversation offers valuable insights into the power of sleep optimization. Topics Covered: • Why temperature is one of the most important factors influencing sleep quality • How sleep patterns change with age • Hormones, menopause, and temperature regulation during sleep • Understanding chronotypes and how they impact sleep habits • The science behind Eight Sleep’s Autopilot technology • Heart rate variability (HRV) and what it reveals about recovery and readiness • How temperature needs change across different sleep stages • Sleep optimization strategies for athletes and active individuals • The impact of exercise timing on sleep quality and recovery • Creating an ideal sleep environment and bedroom temperature • Sleep hygiene habits that support better rest • Innovation in sleep science and technology • Eight Sleep’s new Pregnancy Mode and personalized sleep solutions • The future of sleep optimization, health technology, and longevity CONNECT Eight Sleep on Instagram Marni On The Move Instagram, TikTok, LinkedIn, or YouTube` Marni Salup on Instagram and Playlist on Spotify SUBSCRIBE TO OUR NEWSLETTER Sign up for our monthly newsletter, Do What Moves You, for Marni on the Move updates, exclusive offers, invites to events, and exciting news! SUPPORT THE PODCAST Leave us a five stars and a review on Apple, it’s easy, scroll through the episode list on your podcast app, click on five stars, click on leave a review, and share what you love about the conversations you’re listening to. Tell your friends the episodes you are listening to on your social. Share a screen shot of the episode in your stories, tag us, we will tag you back!  

Jessica Kriegel, Chief Science Officer at Culture Partners, lost her father two days after he came home for good — and spent the next year drinking to forget it. What pulled her out wasn't hustle. It was surrender. Jessica is the Chief Science Officer of Culture Partners, a global workplace consulting firm that drives results for some of the world's largest organizations. She's also the author of Surrender to Lead and host of the CEO Daily Brief podcast. Her research sits at the intersection of culture, belief systems, and measurable business outcomes. In this episode, Kwame and Jessica unpack why the need to control is quietly destroying results — and why the fastest path to what you want requires you to give up the illusion you ever had control in the first place. Connect with Jessica www.jessicakriegel.com Buy the book: Surrender to Lead: The Counterintuitive Approach to Driving Extraordinary Results Contact ANI ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Request A Customized Workshop For Your Company⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Follow Kwame Christian on LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠negotiateanything.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Click here to buy your copy of Finding Confidence in Conflict: How to Negotiate Anything and Live Your Best Life!

Send us Fan MailWhat happens when a Harvard-trained psychiatrist follows the evidence beyond traditional medicine?In this episode of MedEvidence, Dr. Michael Koren sits down with Dr. Carol Locke, physician entrepreneur and Chief Science Officer of OmegaBrite, to explore her remarkable journey from psychiatry and academic research at Harvard's McLean Hospital to pioneering evidence-based omega-3 innovation.Dr. Locke shares how clinical research into mood disorders led to surprising discoveries about omega-3 fatty acids, brain health, inflammation, stress response, and emotional resilience. Together, they break down the science behind omega-3 balance, the role of EPA and DHA, third-party testing, and what clinical trials reveal about omega-3 supplementation's impact on mood, anxiety, inflammation, and overall wellness.You'll also hear insights on physician entrepreneurship, innovation in nutraceutical science, and why evidence-based quality matters when choosing supplements.In this episode: How omega-3s influence brain function and mood  The link between inflammation, stress, and mental health  What clinical trials reveal about omega-3 supplementation  Why supplement purity and testing matter  Emerging science on omega-3 delivery to the brain  Advice for physicians pursuing innovation Be a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on Apple PodcastsWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramX (Formerly Twitter)LinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

While increasingly hostile weather has played a role in growing annual catastrophe losses that now average $132 billion globally, it's actually non-hazard factors such as oil prices, construction materials, and labor costs that account for 80-90% of the cost.  That's the surprising research finding from global reinsurance broker Gallagher Re.  The lines between “primary” and “secondary” perils also need rethinking.Former Florida Deputy Insurance Commissioner Lisa Miller sits down with the chief researcher, and with the chief risk officer of one of Florida's largest property insurance companies to discuss the importance of considering these non-hazard factors in rate calculations, and the need for better building codes, resilience efforts, and potential legislative incentives to mitigate risks and reduce costs. Show Notes Joining Host Miller are Steve Bowen, Gallagher Re's Chief Science Officer and researcher behind the Q1 2026 Gallagher Re Natural Catastrophe and Climate Report, and Ryan Hodges, Senior Vice President of Risk Management for American Integrity Insurance Company, headquartered in Tampa, Florida.  The focus was on the practical implications the research findings have for insurance companies, reinsurers, policymakers, builders, and consumers alike.  Miller opened the discussion by noting that global insured catastrophe losses now average approximately $132 billion annually and that severe convective storms − including thunderstorms, hail, tornadoes, and straight-line winds − have become major contributors to those losses.   The Rise of “Non-Hazard” Cost DriversWhile climate and weather patterns certainly matter, the Gallagher Re report concludes they account for only about 10% to 20% of the increase in insured losses over the past two decades.  “When you're looking at the overall frequency of events, there's not really any data that suggests that we're seeing an overall increase in the number of the events themselves,” said Bowen, who is also a meteorologist.  “We're starting to see some emerging signs that events are behaving a bit more radically, there's more volatility than what we've seen before in the past, but it wasn't enough of an obvious signal for us to feel like this is really what's driving why losses continue to go up.” The report found that 2008 marked a major shift in replacement and exposure costs, and identifies several major non-hazard contributors to the remaining 80% to 90% of rising loss severity, including: Oil price increases affecting asphalt roofing materials  Rising labor and construction costs  Supply chain disruptions  Inflation and consumer price index increases  Claims litigation and social inflation  Urbanization and population growth in exposed regions  All of the above have led to the majority of higher replacement costs following catastrophes.Urbanization and the Expansion of RiskOne of the non-hazard factors noted is the increasing concentration of... (For full Show Notes, visit https://lisamillerassociates.com/episode-64-hidden-cost-drivers-of-severe-storms/) 

Our guest leads the American Heart Association's initiatives on brain health and brain science, including stroke, aging and dementia, migraine, traumatic brain injury and mental health.

Del Potter, PhD is an ethnopsychopharmacologist, chemist, and psychedelic pioneer whose career has moved across some of the most consequential and unconventional edges of the field, from Mesoamerican field research and underground manufacturing to cutting-edge pharmaceutical development and clinical trials. He brings a rare perspective to the psychedelic renaissance: not as a commentator, but as someone who was inside the apparatus that produced these compounds long before the current wave had a name. Dr. Potter holds a PhD from a joint program between the UCSF Medical School and UC Berkeley's Department of Anthropology, specializing in psychiatric anthropology, ethnopsychopharmacology, and neuropharmacology, with additional clinical training at the San Francisco Psychoanalytic Institute. His postdoctoral fieldwork examined shamanic traditions and indigenous psychotherapeutic practice across multiple lineages, including ceremonial psilocybin and Salvia divinorum use among the Mazatec of central Mexico, ayahuasca and yagé ritual among the Shuar of Ecuador, and parallel traditions among the Yanomami of Brazil and the Cofán of Colombia, contributing to Richard Evans Schultes' comprehensive survey of psychotropic botanicals worldwide. A formative mentorship with Alexander Shulgin oriented his chemistry toward novel tryptamine compounds, particularly in the DMT and 5-MeO-DMT structural classes, and he has since developed a portfolio of compounds that retain the neuroplasticity associated with psychedelic receptor activity while producing no psychedelic effect. On the pharmaceutical and biotech side, Dr. Potter served as Chief Science Officer at Leef Holdings, designing what became California's largest fully automated medical cannabis manufacturing facility, and later directed first-in-human 5-MeO-DMT clinical trials at UCSF through his work with Alvarius Pharmaceuticals, followed by a Phase 1 trial at Trinity College Dublin. At University College Dublin, he developed and validated the use of human stem cell-derived brain organoids to assess how psychedelic compounds reverse epigenetic changes caused by substance abuse. In 2023 he founded Spiritus Bioscience to develop novel delivery formats for psilocin, DMT, and 5-MeO-DMT, with the first product entering clinical trials in Australia targeting Alcohol Use Disorder. He currently serves as founder and CSO of BioUnbound Inc., exploring the intersection of psychedelics and bioactive peptides for mental health and longevity applications. Dr. Potter is currently completing his memoir, whose working title is Was a Different Time: Chronicles of a Psychedelic Pioneer in the Reign of the Cartels.Episode Highlights ▶ Del's background supplying California cannabis genetics to the Guadalajara cartel and working at Rancho Bufalo  ▶ Meeting cartel figures Miguel Felix Gallardo and Rafael Caro Quintero, and the fallout from the Kiki Camarena murder  ▶ Manufacturing LSD in Marin County using precursor chemicals sourced through cartel connections  ▶ How a DEA sting led to a federal task force, a stunning offer, and a get-out-of-jail-free card  ▶ Mentorship under Alexander Shulgin and the countercultural milieu of Esalen, Claudio Naranjo, Allen Ginsberg, and Terence McKenna  ▶ Why psychedelics have no intrinsic politics: the compound is the same, the container decides everything  ▶ The retreat economy as product development: when one medicine stops differentiating, operators start stacking  ▶ How the clinical and pharmaceutical models convert ceremony into a billable procedure  ▶ The psychoplastogen pipeline: engineering the experience out so the worker is back at their desk by Wednesday  ▶ Indigenous cosmological governance as a technical achievement, not a romanticized ideal  ▶ The concept of restraint and reciprocity as regulatory systems, and what Western culture has lost  ▶ Why patenting psilocybin protocols and dosing postures is a winnable legal argument  ▶ Publicly funded, community-governed clinics as the only container that can hold what these compounds require  ▶ The mental health crisis as inseparable from the housing, wage, care, and climate crises  ▶ Building a parallel infrastructure: cooperatives, commons defense, and indigenous benefit sharing as models    Dr. Del Potter's Links & Resources ▶ https://delpotterphd.substack.com ▶ https://www.facebook.com/del.potter.75 ▶ @drdelpotter.bsky.social ▶ www.biounbound.com ▶ https://www.instagram.com/potter_del/ Download Beth's free trainings here:  Clarity to Clients: Start & Grow a Transformational Coaching, Healing, Spiritual, or Psychedelic Business:  https://bethaweinstein.com/grow-your-spiritual-business Integrating Psychedelics & Sacred Medicines Into Business: https://bethaweinstein.com/psychedelics-in-business ▶ Beth's Coaching & Guidance: https://bethaweinstein.com/coaching  ▶ Beth's Offerings & Courses: https://bethaweinstein.com/services ▶ Instagram:  @bethaweinstein  ▶ FB: / bethw.nyc + bethweinsteinbiz  Download Beth's free trainings here: Clarity to Clients: Start & Grow a Transformational Coaching, Healing, Spiritual, or Psychedelic Business: https://bethaweinstein.com/grow-your-spiritual-businessIntegrating Psychedelics & Sacred Medicines Into Business: https://bethaweinstein.com/psychedelics-in-business▶ Beth's Coaching & Guidance: https://bethaweinstein.com/coaching ▶ Beth's Offerings & Courses: https://bethaweinstein.com/services▶ Instagram: @bethaweinstein ▶ FB: / bethw.nyc + bethweinsteinbiz

Ep43:Your voice becomes their inner voice(w/ Dr. Lennie Waite) is brough to you by GaimplanDr. Lennie Waite is the Chief Science Officer at Hite EQ and covers a range of topics related to mental performance in sports, the impact of social media on youth athletes, and the psychological aspects of elite performance. Dr. Waite shares insights on the steeplechase, athlete development, and the pressure faced by youth athletes. The discussion also delves into the role of parents in shaping a child's emotional response to sports and the challenges of social media use in the sports industry. The conversation covers the importance of parental emotional support, the impact of competitive coaching on child psychology, and the development of mental skills in youth sports. It emphasizes the need for positive reinforcement and intentional control and focus in young athletes, highlighting the challenges and opportunities in the current landscape of youth sports coaching and development.TakeawaysParental influence on a child's emotional response to sportsThe impact of social media on youth athletes Emotional SupportPositive ReinforcementChapters00:00 Introduction to Dr. Lennie Waite07:32 Elite Performance and Motivation13:40 Track and Field Psychology23:00 Impact of Social Media on Youth Athletes30:26 Parental Emotional Support39:05 Competitive Coaching and Child Psychology50:38 Mental Skills Development in Youth Sports

Some people with cystic fibrosis have seen life-changing results from Trikafta, but not every patient responds to the treatment. The University of Kansas Health System looks at the research helping the group of CF patients who have been left behind by current therapies. Dr. Steve Stites is joined by cystic fibrosis patient Jason White, pulmonologist and critical care specialist Dr. Joel Mermis, and Dr. Matthias Salathe, Chief Research Officer for the University of Kansas and Chief Science Officer of The University of Kansas Health System. Together, they explain how CFTR mutations, theratyping, swab testing, and gene therapy clinical trials may help identify new treatment options for people living with cystic fibrosis and those with the common F508del mutation.

Are you frustrated by a diagnosis of unexplained infertility? What if a "normal" semen analysis is not telling the whole story about sperm health? Could a new male fertility test help explain why fertilization is not happening, even when sperm count, motility, and morphology look fine? In this episode of Brave & Curious, Dr. Lora Shahine welcomes Jeff Lysiak, PhD. He is a reproductive biologist, and co-founder and Chief Science Officer of PS Fertility. He is here to to talk about what standard semen analysis may miss.  Together, Dr. Shahine and Dr. Lysiak explore the science behind sperm fertilization competence, the role of phosphatidylserine (PS) on live sperm, and how Dr. Lysiak's research led to PS Direct, a diagnostic test designed to measure sperm's ability to bind and fertilize an egg beyond traditional semen parameters. Dr. Shahine and Dr. Lysiak also discuss the future of male reproductive health research, including lifestyle factors, environmental exposures, and the growing need for more precise answers earlier in the fertility journey. In this episode you'll hear: [0:39] Meet Jeff Lysiak, PhD [2:01] From Placenta to Sperm [3:24] PS Discovery Explained [5:01] How Sperm Meets Egg [9:02] From Lab to Clinic [10:19] Limits of Semen Analysis [12:46] PS Score and Misdiagnosis [14:12] At Home PS Test Kit [18:20] Where PS Fits Clinically [21:13] Varicocele & Repair Surgery [24:14] Using PS to Guide Care [27:26] Lifestyle Factors [33:006] Future Research Directions [34:21] Where to Find the Test & Connect with Jeff   Resources mentioned:  PSFertility.com   Dr. Shahine's Weekly Newsletter on Fertility News and Recommendations Follow @drlorashahine Instagram | YouTube | Tiktok | Her Books Join the Learn at Pinnacle app to earn FREE CE Credit for listening to this episode! This episode was sponsored by PS Fertility. This episode was produced by Audiotocracy Podcast Production.  

As climate risks intensify, understanding their financial implications is becoming critical for businesses, investors, and homeowners alike. Ed Kearns, Chief Science Officer at First Street, joins Climate Rising to explain how climate data is being translated into actionable financial risk insights. The conversation explores how First Street models physical climate risks—including flooding, wildfire, and extreme weather—and translates them into property-level financial impacts. Ed discusses why traditional tools like FEMA flood maps fall short in a changing climate, and how new approaches combine physics-based modeling with high-resolution data. The episode also examines how climate risk is reshaping real estate markets, insurance systems, and investment decisions, and why transparency is driving a fundamental shift in how risk is priced. Ed reflects on the growing demand for climate risk intelligence and the role of both private markets and public policy in adapting to a warming world.

Show notes: (0:00) Intro (1:09) Ben Rein's path into neuroscience, autism, and empathy research (6:46) A science-based take on manifestation, belief, and action (11:45) Why social connection matters for happiness and long-term health (17:32) Loneliness, stress, and the serious health risks of isolation (24:20) Why older adults may face a major loneliness crisis (28:17) How phones, video calls, and texting change human connection (34:58) Easy ways to upgrade everyday interactions (41:30) Why helping other people can improve your own well-being (45:49) Mental health, behavior change, therapy, and medication (49:50) Where to find Ben and his resources (51:13) Outro   Who is Ben Rein?   Ben Rein, PhD, is an award-winning neuroscientist, author, and science communicator whose research focuses on social behavior, including empathy, autism, MDMA, and the ways digital interaction affects the brain. He earned his PhD in neuroscience from SUNY Buffalo in 2021, where he studied how autism-linked gene changes affect brain function, and later completed postdoctoral training at Stanford University, where he explored the neural basis of empathy. He currently serves as Chief Science Officer of the Mind Science Foundation, is an Adjunct Lecturer at Stanford University, and a Clinical Assistant Professor at SUNY Buffalo. Rein has published more than 20 peer-reviewed papers and is widely known for making neuroscience easy to understand for a public audience of more than one million social media followers.  Connect with Ben: Website: https://www.benrein.com/ LinkedIn: https://www.linkedin.com/in/ben-rein-phd-374605ab/ IG: https://www.instagram.com/dr.benrein/ Grab a copy: https://www.benrein.com/book Links and Resources: Peak Performance Life  Peak Performance on Facebook Peak Performance on Instagram

What if the belly fat, the exhaustion, and the 3 a.m. wake-ups were never about willpower or effort at all? In this episode, Dr. Siobhan Mitchell, a neuroscientist with 25 years of nutrition and cellular health research behind her, breaks down exactly what is happening inside the body during midlife and why the same habits that worked at 35 stop working at 45. Dr. Mitchell is currently the Chief Science Officer at MitoQ, a cellular health company with over $60 million in research, and she brings a level of scientific depth to this conversation that is genuinely rare. What unfolds is not the standard hormone health conversation. Dr. Mitchell explains the critical difference between the two estrogen receptor types, why visceral belly fat is actually a metabolic warning sign and not just a cosmetic frustration, and the truth behind decades of fear-mongering around soy. She also introduces a compound called S-equol that most women have never heard of, despite research showing it may outperform soy isoflavones for menopausal symptoms, joint pain, blood sugar, bone density, and brain health. The catch? Only 20 to 30 percent of Western women can produce it naturally, and the rest need to approach it differently. The conversation goes deeper into mitochondria, aging, oxidative stress, and why protecting your cellular energy production may be one of the most important things you can do in midlife. Natalie also opens up about her own experience with cortisol, soy, and the mom guilt she carried for 18 years over a decision she now knows was completely fine. This one is packed. Whether you are on HRT, avoiding it, or somewhere in the middle, there is something in this episode that will change how you understand your own body. Learn More About Dr. Siobhan Mitchell Instagram ➜ https://www.instagram.com/mitoq   Website ➜ Visit https://www.mitoq.com  and use code NATALIEJILL to save   Thank you to our show sponsors:  TIMELINE: Timeline is offering 20% off your order of Mitopure! Go to https://timeline.com/NATALIEJILL  COZY EARTH: Discover how Cozy Earth turns everyday routines into moments of softness and ease. Head to https://cozyearth.com/ and use my code NATALIEJILL for an exclusive 20% off Free Gifts for being a listener of Midlife Conversations! Mastering the Midlife Midsection Guide: https://theflatbellyguide.com/ Age Optimizing and Supplement Guide: https://ageoptimizer.com   Connect with me on social media! Instagram: www.Instagram.com/Nataliejllfit Facebook: www.Facebook.com/Nataliejillfit   For advertising inquiries: https://www.category3.ca/  Disclaimer: Information provided in the Midlife Conversations podcast is for informational purposes only. This information is NOT intended as a substitute for the advice provided by your physician or other healthcare professional. Do not use the information provided in this podcast for diagnosing or treating a health problem or disease, or prescribing medication or other treatment. Always speak with your physician or other healthcare professional before making any changes to your current regimen.  Information provided in this podcast and the use of any products or services related to this podcast does not create a client-patient relationship between you and the host of Midlife Conversations or you and any doctor or provider interviewed and featured on this show. Information and statements may have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent ANY disease. Advertising Disclosure: Some episodes of Midlife Conversations may be sponsored by products or services discussed during the show. The host may receive compensation for such advertisements or if you purchase products through affiliate links. Opinions expressed about products or services are those of the host and/or guests and do not necessarily reflect the views of any sponsor. Sponsorship does not imply endorsement of any product or service by healthcare professionals featured on this podcast.

The story is often the same when it comes to AI in financial crime teams: 'We tried it, but it didn't stick.'But, the reality is the AI you tested 18 months ago is a relic compared to what is available today.Our expert host, Marit Rødevand is joined by Pedro Bizarro, Co-founder and Chief Science Officer at Feedzai, to tackle the question: Are you at the bleeding edge of AI in financial crime – or already behind?The pair discuss: The next wave of AI innovation in financial crime, the growing AI threats facing the industry, and overcoming the skepticism that still holds so many institutions back.Producer: Matthew Dunne-MilesEditor: Dominic DelargyVideo: Loïs Dunford____________________________________The Laundry explores the complex world of financial crime, anti-money laundering (AML), compliance, sanctions, and global financial regulation.Hosted by Marit Rødevand, Fredrik Riiser, and Robin Lycka, each episode features in-depth conversations with leading experts from banking, fintech, regulatory bodies, and investigative journalism — dissecting headline news, unpacking regulatory trends, and examining the real-world consequences of non-compliance.The Laundry is proudly produced by Strise.Get in touch: laundry@strise.aiSubscribe to our newsletter, Fresh Laundry, here. Hosted on Acast. See acast.com/privacy for more information.

Welcome to the latest episode of LIFTS, your bite-sized dose of the Latest Industry Fitness Trends and Stories. In this episode, hosts Matthew Januszek and Mohammed Iqbal explore one of the most talked-about topics in modern wellness: NAD and the rapid rise of longevity therapies. Joined by Rachele Pojednic, Chief Science Officer at Restore Hyper Wellness, the conversation breaks down what NAD actually is, how it functions within the body, and why it has become such a focal point in energy, recovery, and healthy aging. As wellness clinics, IV therapies, and performance treatments continue to grow in popularity, NAD has emerged as a central molecule in the conversation around optimisation and longevity. However, as interest increases, so too does the gap between consumer awareness, scientific understanding, and real-world application. The discussion explores the biology behind NAD, including its role in cellular energy production, metabolism, and DNA repair, while also examining the different forms of NAD and its precursors, such as NR and NMN. Matthew and Mo share their own experiences with NAD therapies, opening up a broader discussion around delivery methods, perceived benefits, and the difference between anecdotal outcomes and evidence-based practice. As the conversation develops, Rachel highlights the importance of understanding not just the therapy, but the underlying molecule, and why factors such as dosage, delivery method, and cellular transport play a critical role in determining effectiveness. The episode also addresses the wider challenges within the wellness industry, including the speed at which new therapies are being adopted, the influence of biohacking culture, and the growing need for scientific validation and safety data. For operators, this episode provides valuable insight into both the opportunities and responsibilities associated with integrating longevity and wellness services into fitness environments. In this episode, we cover: What NAD is and how it works in the body Why NAD levels decline with age The rise of NAD and wellness clinics The difference between NAD, NR, and NMN Why delivery method and molecule selection matter The gap between wellness hype and scientific evidence Safety considerations, dosage challenges, and unknowns

As artificial intelligence becomes more embedded in everyday work, a new concern is emerging: are we becoming overly reliant on it? In this episode of The HR Room Podcast, Dave and Mary are joined by Dr. Ryne Sherman, Chief Science Officer at Hogan Assessments, to explore the concept of the “AI zombie” — and what it could mean for the future of work. The conversation examines how increasing dependence on AI tools may be reducing critical thinking, decision-making, and cognitive engagement in the workplace. Ryne explains that while AI offers clear productivity benefits, there is a growing risk that employees may begin to “switch off” mentally, delegating too much responsibility to technology. Mary highlights real-world examples of AI misuse, including legal cases where individuals relied on AI-generated information without verifying its accuracy. Together, the panel explores how these behaviours could translate into organisational risks — from poor decision-making to reduced capability development. A central theme throughout the discussion is balance: AI should act as a co-pilot, not an autopilot. The episode emphasises the importance of maintaining human judgment, curiosity, and critical thinking, even as AI becomes more advanced and accessible. The discussion also explores leadership, learning, and organisational responsibility — highlighting how HR leaders must ensure that technology enhances, rather than replaces, essential human skills. Guest • Dr. Ryne Sherman — Chief Science Officer, Hogan Assessments Topics include: • What the term “AI zombie” means and why it's gaining attention • The concept of AI as a “co-pilot” vs “autopilot” • The impact of AI on cognitive ability and critical thinking • Risks in areas like hiring, performance management, and leadership decisions • Lessons from past technological shifts (internet, automation) • Why leadership fundamentals remain unchanged despite AI • The role of HR in managing AI adoption responsibly • Training challenges and the limitations of passive learning systems • The growing importance of creativity, reasoning, and adaptability Key Takeaways for HR Leaders • AI should enhance human capability — not replace critical thinking. • Over-reliance on AI can lead to reduced cognitive skills and poorer decisions. • Strong communication skills are essential for effective AI use. • Curiosity and continuous learning are key traits in an AI-driven workplace. • Leadership fundamentals (integrity, judgment, expertise) remain unchanged. • AI can improve productivity — but may also degrade performance if misused. • HR must actively guide how AI is used within organisations. • Training should focus on critical thinking and responsible AI use. • Passive learning approaches (e.g. LMS-only training) are insufficient. • Human skills — empathy, judgment, communication — are more valuable than ever. • Organisations must guard against “skill atrophy” over time. • The real risk isn't automation — it's abdication of responsibility. Get in Touch If you're not already following us on LinkedIn, please do. If you have suggestions for future episodes, or if you'd like to join us as a guest, reach out to Dave Corkery at connect with him on LinkedIn. About The HR Room Podcast The HR Room Podcast is brought to you by Insight HR — where we speak with HR leaders, experts and practitioners across Ireland about the issues shaping the world of work today. If you're enjoying the podcast, please share it with colleagues or friends and leave us a review. We love to hear your feedback, we take requests, and we're always here to support you with your HR challenges. Immediate HR support

Welcome to Quick Hits — where we bring you the most impactful moments from past episodes in under 15 minutes. Today's clip comes from one of our most replayed conversations. If you want the full episode, check the link in the description below.   Listen to the full peptide here: https://karenmartel.com/blogs/podcast/unraveling-the-science-of-low-dose-herbal-melatonin-with-deanna-minich    Dr. Deanna Minich, is a Certified Functional Medicine Practitioner, with a Masters of Science degree in Human Nutrition , and a Doctorate in Medical Sciences. She is an international lecturer, educator, and author, with over twenty years of experience in academia and in the food and dietary supplement industries, currently serving as Chief Science Officer at Symphony Natural Health. Through her talks, workshops, groups, and in-person retreats, she helps people to practically and artfully transform their lives through nutrition and lifestyle. Dr. Minich, brings us into the world of melatonin in today's episode, going beyond its well-known role in sleep regulation to explore its lesser-known functions. We discuss how melatonin impacts digestive health, its profound implications for women in menopause, and the influence of nutrients on circadian rhythms. We also examine the controversies surrounding melatonin supplementation, unraveling its powerful antioxidant properties and the importance of finding the right dosage for individual health needs.   Visit her at: www.deannaminich.com.    In this episode: Why understanding melatonin's roles is crucial for women, particularly during menopause. How melatonin production occurs in the pineal gland and the gut. Why nutrient intake affects circadian rhythms and overall health. How irregular schedules can disrupt natural body rhythms, plus solutions to mitigate this. Why it's important to take an individualized approach to nutrient supplementation. How high-dose melatonin may impact the body's systems and hormone balance. Why receptor saturation from high melatonin doses can decrease effectiveness. How melatonin serves as a powerful antioxidant with an appropriate dosage. Why moderation in antioxidant use, including melatonin, is necessary for health. How personalized healthcare helps in understanding supplement and medication interactions. Why melatonin's role extends to the health of bones, joints, the gut, hair, skin, and nails. How lifestyle choices and hormonal balance impact menstrual health. Why melatonin can help manage perimenopausal symptoms like hot flashes and night sweats. How the timing and dosage of melatonin supplementation can be optimized for individual needs. Why continuous adjustments in melatonin intake may be needed as one's health circumstances change.     Sponsors Get 15% off our Progest Sleep oil with coupon sleep.     Are you in perimenopause or postmenopause and struggling with symptoms—but not getting the support you deserve? At Midlife Solutions, we specialize in hormone optimization for women in midlife. Our all-female clinical team offers telehealth care across all 50 U.S. states, with the ability to prescribe bioidentical estrogen, progesterone, testosterone, and thyroid medication.   Book your FREE Hormone Discovery Call Find out what's really driving your symptoms and what your next best steps are.   Visit the website: https://karenmartel.com   Shop the Midlife Solutions Store Over-the-counter bioidentical hormone creams and oils — no prescription needed. Including: • Progesterone • Estrogen Face Cream • Vaginal Moisturizer and more!   Take the Hormone Quiz Discover hidden hormone imbalances that could be driving your symptoms. Get personalized results (and yes, they may surprise you).   Women's Peptide Weight Loss Program Clinically guided, hormone-aware weight loss for midlife women.   Midlife RESET HRT Program A complete, supportive approach to hormone replacement therapy in midlife.   Your host: Karen Martel Certified Hormone Specialist, Transformational Nutrition Coach, & Weight Loss Expert   Karen's Facebook Karen's Instagram

What does it mean to build something that has never existed before? In this episode of StartUp Health NOW, Unity Stoakes sits down with CEO & Co-founder Valerie Gharagouzloo and Chief Science Officer & Co-founder Codi Gharagouzloo, PhD, of Imaginostics, the health technology company reimagining what MRI can tell us about the human body. Their platform, built on a technology invented by Codi during his PhD research in 2012, creates a new quantitative data layer inside existing MRI scanners, one that replaces toxic contrast agents, delivers images judged ten times better than the gadolinium standard, and generates vascular biomarkers measurable for the first time at the individual patient level. StartUp Health community members Valerie and Codi break down the difference between their two platforms, ImagiView™ and ImagiSight™, explain why blood-brain barrier leakage matters for Alzheimer’s and how they are finally able to measure it in individual patients, and share what their commercialization partnership with Siemens means for getting this technology into hospitals. Twice nominated for the Prix Galien, backed by four federal research agencies, and now running a 96-patient study funded by the Alzheimer’s Drug Discovery Foundation, Imaginostics is one of the most rigorously validated zero-to-one technologies in health innovation today.   Are you ready to tell YOUR story? Members of our Health Moonshot Communities are leading startups with breakthrough technology-driven solutions for the world's biggest health challenges. Exposure in StartUp Health Media to our global audience of investors and partners – including our podcast, newsletters, journal, and YouTube channel – is a benefit of our Health Moonshot Membership. If you're mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit. » Learn more and join today. Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

Tom Knapman is a PhD-qualified biochemist. Last year, he was working for Sciex, whose campaign on proteomics (don't worry, we'll explain that in the episode) was a perhaps unlikely winner of a Grand Prix gong at The Drum Awards last year. This year he's jumped ship into a perhaps almost-unique role: chief science officer at a creative agency. He tells The Drum why he thinks boom times are coming for science comms. Hosted on Acast. See acast.com/privacy for more information.

Send me a messageWhat if voluntary carbon markets are either a vital climate tool... or a polished excuse to delay real decarbonisation?In this episode of Climate Confident, I'm joined by Dr Jennifer Jenkins, Chief Science Officer at Rubicon Carbon, to unpack one of the most contested questions in climate tech and net zero strategy: what role, if any, should voluntary carbon markets play in real-world emissions reduction? At a time when companies are under pressure to decarbonise, prove integrity, and navigate fast-moving policy shifts, this debate matters more than ever.We dig into why some firms see carbon credits as a practical way to close the gap between ambition and operational reality, and why others see them as a dangerous distraction. You'll hear why quality, additionality, MRV, and long-term offtake agreements are becoming central to the future of the market, and why high-integrity supply may be far tighter than many buyers realise.Jennifer also explains how buyers like Microsoft are shaping demand, how voluntary and compliance markets may be starting to converge, and why policy tools like CBAM could reshape the market faster than most people expect. You might be shocked to learn that one of the clearest ways to think about this space is as outsourced mitigation, a framing that makes the economics easier to grasp, but also exposes the credibility problem at the heart of the whole system.

I am so excited to share this conversation with you. In this episode, I sit down with Dr. Mark Ratner, Chief Science Officer at Theralogix, to talk about a topic I've become incredibly passionate about: NAD+ and its role in egg quality and fertility. If you've been wondering what NAD+ actually is, why your eggs need it, and whether supplementation could make a real difference in your IVF or egg freezing outcomes, this is a must-listen. We get into the science of how NAD+ and sirtuins work together in our cells, why their decline with age is such a big deal for egg health, and the emerging research — from mouse studies to a promising new human trial — suggesting that boosting NAD+ levels could improve fertilization and pregnancy rates. I also share a personal story about a patient whose results completely blew me away after she started NAD+ supplementation on her own. This is the kind of conversation that gets me fired up about the future of fertility medicine. In this episode, we cover: What NAD+ is and how it's present in every cell of your body The role of mitochondria in egg development and why eggs require more energy than any other cell What sirtuins are and how SIRT1 appears to regulate ovarian reserve How the age-related decline in NAD+ and sirtuins creates a "double whammy" for egg quality The connection between NAD+, chromosomal abnormalities (aneuploidy), and diminished ovarian reserve Key findings from mouse studies and a new human study showing doubled fertilization and clinical pregnancy rates with NAD+ boosting How to start supplementing and what to look for Resources: Theralogix website: theralogix.com — Use discount code EGG for ~15% off The IVF Class at The Egg Whisperer School  The Egg Whisperer Show podcast on Spotify and Apple Podcasts Dr. Aimee's Supplement Stack information Subscribe to my YouTube channel for more fertility tips! Join Egg Whisperer School Subscribe to the newsletter to get updates Dr. Aimee Eyvazzadeh is one of America's most well known fertility doctors. Her success rate at baby-making is what gives future parents hope when all hope is lost. She pioneered the TUSHY Method and BALLS Method to decrease your time to pregnancy. Learn more about the TUSHY Method and find a wealth of fertility resources at www.draimee.org.  

What if the biggest decisions shaping your farm today are actually being made a decade in advance?In this episode of the AgCulture Podcast, Paul sits down with Tony Klemm (CEO) and Tom Meade (Chief Science Officer) from Enko Chem at the World AgriTech Summit to explore how the next generation of crop protection is being built.Unlike most of agriculture, where decisions are made season to season, Enko is working on problems that don't fully exist yet — identifying future pest, disease, and resistance challenges and developing solutions years before they reach the farm gate. Using advanced discovery technologies adapted from the pharmaceutical industry, they are rethinking how new chemistries are identified, tested, and brought to market.This conversation dives into the shift happening in crop protection — from legacy molecules and slowing innovation pipelines to a new model built on collaboration, precision application, and more sustainable, highly targeted solutions.If you want to understand where chemistry, regulation, and farm productivity are heading — and what tools will be in your toolbox 10 years from now — this is a conversation worth paying attention to.Listen to the episode now!MEET THE GUESTSTony KlemmTony Klemm is the CEO of Enko Chem, Inc. with over 30 years of experience in agricultural biotechnology. Prior to joining Enko in 2025, he served as VP of Global Business Development and Licensing at Corteva Agriscience, where he led strategic growth and innovation in the Seeds Business Unit. Tony has held leadership roles at Dow AgroSciences and DowDuPont and has extensive experience in global negotiations, partnerships, and commercialization strategies. He holds an Executive MBA in Agricultural Economics from Purdue University and a Bachelor's degree from Iowa State University.Tom Meade, Ph.D.Tom Meade is Chief Science Officer at Enko Chem and has more than 30 years of experience in crop protection and trait discovery. He began his career at Mycogen and later held leadership roles at Dow AgroSciences, where he led global traits discovery. Tom has authored multiple scientific publications and holds 27 U.S. patents. He earned his Ph.D. in Entomology from UC Riverside.ABOUT THE PODCASTDiscover the world of agriculture with the "Ag Culture Podcast". This podcast will be a gateway for those passionate about agriculture to explore its global perspectives and innovative practices.Join Paul as he shares his experiences in the agricultural industry, his travels and encounters with important figures around the world.Available on YouTube, Spotify and Apple Podcasts.Subscribe at http://www.agculturepodcast.com and keep an eye out for future episodes, bringing insights and stories from the vibrant world of agriculture.

Episode 61: Lasers to the rescue!  Xcimer CEO/co-founder Conner Galloway and co-founder Alex Valise are building the world's most powerful gas lasers to ignite fusion energy. With $170MM of capital raised, they are, step-by-step, commercializing scientifically validated concepts to deliver big, beautiful, clean energy.   00:00 Welcome  00:28 Meet Conner, Alex, and Xcimer  12:44 Fusion Basics Explained  18:41 Inside the Fuel Pellet  28:49 Excimer Lasers and Pulse Compression  35:08 Warehouse Scale Facility  41:55 Liquid Wall Target Chamber  49:27 Efficiency and Target Gain  52:04 Roadmap Phoenix to Athena  58:56 Directed Energy Spinoffs  01:00:44 Conclusion

In this Stay Tranquilo episode, we sit down in the Florida Everglades with Dr. Steve Davis, Chief Science Officer of The Everglades Foundation, to talk about Everglades restoration, Lake Okeechobee water flow, wildlife conservation, and why the Everglades are critical to South Florida's water supply. Subscribe for more Stay Tranquilo conversations on South Florida culture, environment, sports, and community.

I'm thrilled to bring you this conversation about a breakthrough in male fertility diagnostics that's been literally hiding in plain site. In this episode, I'm joined by Dr. Jeff Lysiak, PhD, co-founder and Chief Science Officer at PS Fertility, to discuss phosphatidylserine (PS) and how this critical molecule on sperm is revolutionizing how we diagnose male infertility. Jeff shares the fascinating story of how his research at the University of Virginia led to discovering that PS on the surface of sperm is essential for fertilization and how traditional semen analysis completely misses this vital piece of the puzzle. Read the full show notes on my website.  This episode addresses a frustration I've experienced for years in my practice: couples with "normal" semen analysis results who still have trouble when it comes to trying to conceive. Research shows that 20-30% of men with normal basic semen analysis could still be infertile, and we've had no way to identify them, until now.  In this episode, we cover: What phosphatidylserine (PS) is and why it's critical for sperm to fuse with and fertilize an egg The major limitations of standard semen analysis (count, motility, morphology) and why 20-30% of men with "normal" results may still be infertile How the PS Detect test works using flow cytometry to assess over 10,000 sperm per sample The connection between varicocele and low PS scores—and how varicocelectomy surgery can restore PS levels to normal ranges When the PS test should be ordered in a fertility workup and what to do if scores are low Early data showing over 30% of men seeking fertility treatment have low PS scores, including those with normal semen analysis How this test can prevent women from undergoing unnecessary treatments when the male factor is undiagnosed Resources: PS Fertility website: psfertility.com PS Detect at-home test kit Nature Communications publication on phosphatidylserine and fertilization Dr. Aimee's Supplement Stack The TUSHY Method OVANAD+ by Theralogix. Use code EGG. Would you like to learn more about IVF?Click here to join Dr. Aimee for The IVF Class. The next live class call is on Monday, April 20, 2026 at 4pm PST, where Dr. Aimee will explain IVF and there will be time to ask her your questions live on Zoom.   Dr. Aimee Eyvazzadeh is one of America's most well known fertility doctors. Her success rate at baby-making is what gives future parents hope when all hope is lost. She pioneered the TUSHY Method and BALLS Method to decrease your time to pregnancy. Learn more about the TUSHY Method and find a wealth of fertility resources at www.draimee.org. Other ways to connect: Subscribe to my YouTube channel for more fertility tips Join Egg Whisperer School Subscribe to the newsletter to get updates   Keywords: male infertility, phosphatidylserine, PS score, PS Detect, male fertility testing, semen analysis limitations, sperm function, fertilization competence, varicocele, unexplained infertility, IUI success rates, male factor infertility, reproductive urology, Jeff Lysiak, PS Fertility, sperm egg fusion, fertility diagnostics, at-home sperm test, idiopathic male infertility, fertility workup, egg whisperer show, Dr. Aimee

Midlife is a time for rebirth… a time to come into who you truly are.  In today's episode, I'm sitting down with the brilliant Dr. Deanna Minich to dive into how this stage of life can bring you to the best version of yourself after years of balancing roles, expectations, and responsibilities.  Dr. Minich shares why midlife is the perfect time to rediscover your voice, clarify your needs, and define your non-negotiables so you can live the next chapter on your own terms.  We're reframing menopause not as an ending, but as the beginning of a powerful second half of life filled with purpose and authenticity.  Ready to reclaim your energy and step into midlife with clarity and confidence?  Tune in here!  Deanna Minich, PhD, MS, CNS, IFMCP Deanna Minich is a nutrition scientist, international lecturer, educator, and author with over 25 years of experience in academia and in the food and dietary supplement industries. She's the Chief Science Officer at Symphony Natural Health, and has written seven books and over 50 scientific publications. Her work aims to help others live well by using therapeutic lifestyle changes that impact their physical, emotional, mental, and spiritual health. IN THIS EPISODE Uncommon signs that you're entering  perimenopause  The importance of musculoskeletal strength in midlife What's really going on with female hormones in perimenopause  Setting boundaries in midlife in your relationships and career Balancing lifestyle changes and hormone replacement therapy for optimal results  How to navigate stress and manage your nervous system Finding your authentic self in perimenopause and beyond How to connect with Dr. Deanna for more midlife expertise  QUOTES “I think it's a really powerful system and I think the best thing for women, no matter if you're going through perimenopause, you're just about to enter, or even if you're post, it's really connecting into that wisdom within that we have as the endocrine system.” “There's no way I could ever do women's health on my own. I want to be connected to a collaborative, to a team, to other people in the space where we rise together and we really get the message out. So that's what I've been doing.” “Here's the message for women: we all need a way to bring ourselves into better coherence, better emotional, mental status, like where we feel in the zone.” RESOURCES MENTIONED Use code ENERGIZED and get 10% off on your Troscription Order http://troscriptions.com/ENERGIZED Dr. Deanna's Website Dr. Deanna on Instagram Dr. Deanna on Facebook Symphony Natural Health Website RELATED EPISODES  724: Age Like A Girl: Why Midlife Women Stop Shrinking and Start Leading with Dr. Mindy Pelz  721: No, It's Not All in Your Head: The Medical Truth About Perimenopause with Dr. Jila Senemar 720: Why No One Talks About Loneliness in Midlife—And Why It's Not Just You  574: The Connection between Trauma, the Immune System, and Autoimmune Disease: Lab Testing and Solutions with Dr. Sara Szal Gottfried

"We, the people we can definitely keep the pressure on, not only on our lawmakers, our governors, our mayors, our senators, our Congress people. We have to keep reminding them that we care about these issues…There's a real key also to the future reimagining, asking companies to reimagine themselves as energy companies, not oil companies or gas companies, but energy companies. So all of these pressure points are incredibly important. We all have favorite stores, favorite brands that we shop on. If you love Walmart writing to the customer services and to the president of Walmart saying, 'Hey, get those solar panels on all of our Walmart stores. We want to do our part. They care. They care about consumer response. It's important to say that you care. You want them to care." Dominique Browning on Electric Ladies Podcast This Women's History Month 2026, it's critical that all our elected officials at all levels know that we care about climate change, clean air, clean water and protecting the environment. That pressure is what makes them pass legislation that addresses these issues. How? Listen to Dominique Browning, Founder and head of Mom's Clean Air Force, who is also a Vice President at the Environmental Defense Fund, in this fascinating conversation with Electric Ladies Podcast host Joan Michelson.   You'll hear about: ●        How to pressure your Mayor, Senators, Congresspeople, state legislators, governors, the head of the EPA, the president, and even your School Board members to pass legislation to address the climate crisis and protect our clean air, clean water and environment. ●        How states and cities are leveraging Inflation Reduction Act and infrastructure Act funding and incentives, still, for a range of clean energy and climate solutions, such as electric school buses and solar panels. ●        How important it is to show gratitude when elected officials do the right thing. ●        Plus, career advice, such as:   "Just say yes, say yes to everybody who wanted you to do a project or consult on something or talk about something, meet, brainstorm, et cetera. And slowly but surely, I started building up a network of people who were interested in the same things I was interested in…Another piece of advice I got …(was) 'you got to go with the love.'…Over time, I began to see that what she was talking about was think about what you love, what you're passionate about, and what you can do… And that's very motivating, especially when things are difficult." Dominique Browning on Electric Ladies Podcast Subscribe to Joan's weekly newsletter here to stay abreast of episodes, trends, career advice, and events where Joan is speaking. You'll also like: ·       How to Talk About Climate In A Polarized Culture -- with Katharine Hayhoe, Ph.D., Climate Scientist, Chief Science Officer at The Nature Conservancy & Professor, Texas Tech University ·       The Politics of Climate & Energy – with Congresswoman Chrissy Houlahan, Co-Chair, Bipartisan Climate Solutions Caucus ·       How to Rebuild Cities After Disaster  – with Majora Carter, Urban Development Expert ·       How Design & Technology Are Redesigning Cities – Nikki Greenberg, Real Estate of the Future, live at the Smart City Expo World Congress 2025 ·       Unique Practical Climate Solutions For Cities – Joan's panel at the Smart City Expo World Congress in Barcelona   Subscribe to our newsletter to receive our podcasts, blogs, events and special coaching offers. Thanks for subscribing on Apple Podcasts or iHeartRadio and leaving us a review! Follow us on Twitter @joanmichelson

AI data centers are going to double their power consumption by 2030—so where's all that energy coming from? One answer is fusion, the same process that powers the sun.In this episode of The Neuron, we're joined by Brandon Sorbom, Chief Science Officer and Co-founder of Commonwealth Fusion Systems, to explore how his company is racing to build the world's first commercial fusion power plant—and how AI is helping them get there faster.Brandon explains why fusion has been "30 years away" for decades, what changed with high-temperature superconducting magnets, and why fusion is fundamentally safer than fission (hint: fusion is "default off"). We dive into CFS's collaborations with Google DeepMind and NVIDIA, what it takes to wrangle 10,000 unique parts, and when we might actually see fusion on the grid.You'll learn:• What fusion actually is (and why it's not nuclear fission)• Why high-temperature superconducting magnets changed everything• How AI is accelerating plasma control and simulation• The safety profile that makes fusion regulated like an MRI, not a reactor• When CFS expects to hit Q > 1 (net energy) and beyondTo learn more about Commonwealth Fusion Systems, visit https://cfs.energy.For more practical, grounded conversations on AI and emerging tech, subscribe to The Neuron newsletter at https://theneuron.ai

So, there are dire wolves living on Earth again. They were “de-extincted” by Colossal Biosciences. And today on the show their Chief Science Officer joins me to share her view on why the de-extinction matters — not as a science project, but because it will help solve problems that threaten every species on earth, including us. Beth Shapiro is the Chief Science Officer at Colossal Biosciences, and she helped to bring back the dire wolf or, as others call it, a gray wolf with 20 genetic edits. There is a fierce debate about what de-extinction even means, and we discuss that, but whatever you call them, there are now three big wolves living in an undisclosed location and they wouldn't be there if not for the DNA that Beth and her team edited. Colossal is also working to bring back the wooly mammoth, the Tasmanian tiger, the dodo and other animals that have long been extinct. Why? Listen to find out… Chapters:(01:19) - The Most Oprah Question Beth's Ever Been Asked (03:04) - Moonshots Require You to Create a Giant List of Problems (04:19) - The Things We'll Solve Along the Way, a la the Original Moonshot… to the Moon (05:57) - Beth's Journey: From Broadcast Journalism to Ancient DNA (09:13) - How a Sediment Core Solved a Mammoth Mystery (11:36) - Why Charismatic Animals Matter (a.k.a. Why Riz Is Everything) (12:38) - What's Up With Romulus, Remus, and Khaleesi? (14:19) - But Are They Really “Dire Wolves”? The Controversy Over 20 Genetic Edits (21:45) - Should We Do This? Beth's Ethics Framework for Builders (23:51) - Advice for Moonshot Builders (25:10) - Why We Want Dodos, Mammoths, and Thylacines Back Links & Resources:Colossal BiosciencesBeth ShapiroPopTech -- a conference I love!  Support Future Around & Find OutFollow Dan on LinkedInGet the free Future Around & Find Out newsletterBecome a paid subscriber and help future proof the podcast!Sponsor the show? Are you looking to reach an audience of senior technologists and decision-makers? Email me: dan@modernproductminds.com---Music by Jonathan Zalben

We find ourselves in environments like homes, offices, airports, even hospitals where invisible factors can shape everyday wellbeing. But how much does the air we breathe actually affect immune health? And are the filtration systems in our homes and public spaces truly doing what we think they are? In this episode, Natalie Tysdal sits down with Dr. Kathryn Worrilow, founder and Chief Science Officer of LifeAire Systems. With decades of research in clinical environments from IVF laboratories to senior living communities and acute-care hospitals, Dr. Worrilow shares what science has revealed about indoor air quality, airborne pathogens, and immune protection. This conversation is about awareness, not fear. Because you can't manage what you don't measure. You'll learn: • How invisible airborne pathogens, far beyond dust and allergens, can influence immune health • Why standard air filtration may capture particles but not eliminate them • The difference between purification technologies and why byproducts like ozone matter • What hospitals have learned about air quality and infection rates • Practical questions you can ask about the air in your home, office, school, or healthcare setting Midlife is often a season of reassessment of hormones, immunity, and resilience. Understanding the role air quality plays in overall wellness is one more layer of informed decision-making. This episode offers steady, research-backed insight to help you feel empowered in the spaces you live and work. episode webpage with more info: https://www.natalietysdal.com/post/indoor-air-quality-and-immune-health-what-women-in-midlife-need-to-know Natalie's website: https://www.natalietysdal.com Follow Natalie: Instagram: https://www.instagram.com/ntysdal TikTok: https://www.tiktok.com/@ntysdal Facebook: https://www.facebook.com/NatalieTysdal Listen now and subscribe for weekly conversations that help women make sense of midlife health—without hype, panic, or overwhelm. DISCLAIMER: Natalie Tysdal is a health journalist, not a licensed medical professional. This podcast is for informational purposes only and is not a substitute for medical advice, diagnosis, or treatment.

Evan Zhao is the Co-founder and CEO of Pacagen, using biotechnology to revolutionize consumer products. Before Pacagen, he served as Chief Science Officer at ODDITY, and previously built and sold Revela. He earned a PhD in Chemical Engineering from Princeton University, and completed work as a Schmidt Science Fellow at Harvard.See omnystudio.com/listener for privacy information.

Today, I'm delighted to welcome Dr. Yael Joffe, a leading expert in nutrigenomics who speaks internationally at conferences on translating the science of genetics into clinical practice. She holds a PhD in nutrigenomics from the University of Cape Town, where her research focused on the genetics of obesity. I met Yael earlier this fall and decided to invite her on the podcast to explore the growing field of lifestyle genetics. In our conversation today, we dive into the effects of nutrigenomics, nutrition genetics, and SNPs, which she refers to as spelling changes in our DNA. We cover genetic testing in the industry, red flags, DNA health, and her polygenic approach to weight loss resistance. We also discuss both perimenopause and menopause from the perspective of genetics and epigenetics, and the role of insulin signalling and glucose. Yael's insights are deeply informative. Her pioneering work on 36 metabolic pathways and her ability to make complex genetic information accessible and actionable make this a truly invaluable conversation. IN THIS EPISODE, YOU WILL LEARN: Women and gaining weight after starting HRT Neurotransmitters and what they reveal about mood, anxiety, and addiction tendencies Why do certain people break down dopamine and serotonin either too fast or too slowly? How touch and genuine connection can switch on feel-good genes Sunlight, weather, and environment affect genetic expression. What acupuncture and infrared therapies do at the gene level Why hormones are only part of the picture when addressing midlife weight gain How glucose regulation and insulin sensitivity shift through menopause Dr. Joffe's polygenic testing model connects multiple pathways rather than single genes How Yael's approach to genetic testing differs from that of others in the field Bio: YAEL JOFFE, PhD  Yael is globally recognized as a leading expert in nutrigenomics. In 2000, she was part of the team that built the first lifestyle genetics test, and since then has been responsible for creating many others. She is the author of four books: The Power of Genetics, It's Not Just Your Genes, Genes to Plate, and SNP Journal. Yael has been published in multiple peer-reviewed scientific journals, hosts the Power of Genetics podcast, and is a highly regarded speaker in genetics. Yael built the first online nutrigenomics platform for clinician education and has developed and supervised genomics courses around the world. She has trained thousands of healthcare practitioners globally, also teaching at Rutgers University and the Maryland University of Integrative Health. In 2018, Yael founded 3X4 Genetics and now serves as its Chief Science Officer.    Connect with Cynthia Thurlow   Follow on X, Instagram & LinkedIn Check out Cynthia's website Submit your questions to support@cynthiathurlow.com Join other like-minded women in a supportive, nurturing community (The Midlife Pause/Cynthia Thurlow)  Cynthia's Menopause Gut Book is on presale now! Cynthia's Intermittent Fasting Transformation Book The Midlife Pause supplement line Connect with Dr. Yael Joffe 3X4 Genetics Instagram Facebook

Dr. Riley Kirk welcomes Dr. Harold Han, Chief Science Officer and Co-Founder of Vertosa to explore the fascinating world of the science powering modern cannabis beverages and infused products. Known in the industry as “The Happy Chemist,” Dr. Han explains how emulsion technology solves the classic oil-and-water problem that makes cannabinoids difficult to incorporate into drinks. The conversation breaks down how water-compatible cannabinoids are created, why droplet size and consistency matter for potency and onset, and how stability challenges differ between beverages and gummies. They explore oxidation rates of major cannabinoids, packaging risks like “scalping” from can liners, and new patented approaches to preserving potencyin infused drinks. They also examine the full beverage development pipeline, from cannabinoids and infusion technology to formulation, manufacturing, testing, and distribution, highlighting the many points where potency and quality can be affected. Dr. Han clarifies the difference between nano and micro emulsions, why most commercial cannabis drinks use nano systems, and how natural emulsifiers influence formulation choices. The discussion further explores how the human body processes emulsified cannabinoids, why food (especially fat) changes edible effects, and how fast-acting beverages work at a physiological level. They discuss new human research initiatives, patient applications such as consistent dosing without sugar or smoke, and how standardized emulsions could transform both clinical research and at-home use. Looking ahead, Dr. Han shares insights on full-plant formulations, the future of cannabis as a precise delivery system for medicine, and the role of science-driven innovation in making cannabinoids more accessible, consistent, and scalable across recreational, wellness, and medical markets. Chapters 00:00 Welcome + Meet Dr. Harold Hahn (“Happy Chemist”) & What Vert Does 00:52 From Cannabis Stigma to Conscious Living: Harold's Personal Journey 02:18 The Oil-and-Water Problem: Emulsifiers Explained for Cannabis Drinks 04:13 Vert's Water-Compatible Cannabinoids: Droplet Size, Consistency & Effects 09:48 Stability Deep Dive: Physical Separation, Oxidation Rates & Gummies vs Beverages 16:05 Packaging Pitfalls: Can Liners, “Scalping,” FTIR Testing & a New Patent Fix 22:49 Beverage R&D Checklist: The 7-Step Supply Chain + Taste/Mouthfeel Priorities 27:16 Flavor Wars: Tasteless THC vs “Tastes Like the Plant” 28:37 Nano vs Micro Emulsions Explained (It's Not Just Size) 31:40 Why Most Cannabis Drinks Use Nano: Natural Emulsifiers & Custom Control 34:38 Fast-Acting vs Slow-Acting: What Your Gut Does With Emulsions 37:41 Food Effects + The New UCSF Cannabis Beverage PK Lab 40:32 Patient Benefits: Consistent Dosing, No Sugar, Full-Plant Medicine 44:23 Research, DIY Possibilities & Big-Picture Wrap-Up   Connect with Dr. Harold Han LinkedIn: Harold Han Ph.D. (The Happy Chemist) Company: Vertosa — https://vertosa.com/   Want Exclusive Content and Ad-Free Episodes? Join the Bioactive Patreon community for as little as $1/month to ask guests your burning questions, access exclusive content, and connect with Dr. Kirk one-on-one. www.Patreon.com/Cannabichem

In this episode, Peter Swartz, Co-Founder and Chief Science Officer at Altana, reveals how the company's AI-powered supply chain knowledge graph has helped stop hundreds of millions of dollars in forced labor goods from crossing borders and contributed to some of the largest counter-narcotics seizures in investigators' careers. Peter shares the real-world impact Altana is making across both the public and private sectors.Peter breaks down how Altana's multi-tier supply chain visibility works to trace forced labor cotton through global networks, how dual-use chemicals are being diverted into fentanyl production, and how the platform helps governments and enterprises collaborate to avoid billions of dollars in trade disruptions while saving hundreds of millions in tariff fees.Key Topics Covered- How Altana blocked hundreds of millions of dollars in forced labor goods at U.S. borders- The role of AI knowledge graphs in mapping multi-tier global supply chains- How Altana supports CBP enforcement of the Uyghur Forced Labor Prevention Act- Product passports and how they expedite legitimate goods through customs- The difference between forced labor entering legit supply chains vs. legit goods entering illicit ones- How logistics companies use Altana to prevent their networks from being misused- Proactive vs. reactive approaches to supply chain risk using probabilistic AI models- Scenario modeling for geopolitical disruptions including Taiwan and global conflicts- Saving billions in supply chain disruptions and hundreds of millions in tariff feesEpisode Timestamps00:00 - Introduction and overview of Altana's real-world impact00:41 - Understanding forced labor as a multi-tier supply chain problem03:09 - Hundreds of millions in forced labor goods stopped at borders03:45 - How the AI knowledge graph maps global supply chain connections04:15 - Working with CBP on the Uyghur Forced Labor Prevention Act04:35 - Product passports and expediting goods through customs04:51 - Counter-narcotics and the dual-use chemical problem05:45 - Helping logistics companies stop network misuse06:27 - From alert to action and the system handoff process06:49 - Responsible AI and the role of human-in-the-loop decisions07:33 - Proactive vs. reactive supply chain intelligence08:08 - Scenario modeling for geopolitical disruptions and resiliencyAbout Peter SwartzPeter Swartz is Co-Founder and Chief Science Officer at Altana. He has spoken on global trade, supply chains, and machine learning at the World Trade Organization, the World Customs Organization, the U.S. Court of International Trade, and the National Academies of Medicine. Previously, Peter was Head of Data Science at Panjiva, listed as one of Fast Company's most innovative data science companies in 2018 and later acquired by S&P Global. He holds patents in machine learning and global trade, and completed his education at Yale, MIT, and EPFL.About AltanaAltana is the world's first Value Chain Management System, providing AI-powered supply chain intelligence to governments, enterprises, and logistics providers. The platform is built on a proprietary knowledge graph comprising more than 2.8 billion shipments, tracking over 500 million companies and 850 million facilities globally. Altana covers more than 50% of global trade, making it the most comprehensive and accurate supply chain map available.Resources Mentioned- Altana Atlas platform and AI knowledge graph- U.S. Customs and Border Protection (CBP)- Uyghur Forced Labor Prevention Act (UFLPA)- Product passports for cross-border compliance- Altana's disruption and tariff scenario modeling toolsPeter's Socials:LinkedIn — https://www.linkedin.com/in/pgswartz/Partner LinksBook Enterprise Training — https://www.upscaile.com/

Dr. Olivier de Hon is the Chief Science Officer and Director of Intelligence and Investigations at Doping Authority Netherlands. In this episode, he shares more about the history of the organization, progress in estimating doping prevalence, challenges in assessing the effectiveness of anti-doping programs, and considerations for promoting clean sport among elite athletes as well as recreational athletes in gyms and fitness centers.

In this episode, we sit down with Dr. Rachele Pojednic, a Stanford faculty member and Chief Science Officer at Restore Hyper Wellness, to talk about the confusing gray zone between wellness fads and real science. We get into why so many health trends (like saunas, cold plunges, supplements, red light therapy, and IV drips) feel like they work… even when the research hasn't caught up yet. Rachele breaks down how wellness companies and influencers often take small, weak studies and turn them into massive claims — and how to spot that as a consumer. We also talk about what actually looks promising in the research right now (yes, creatine comes up), and why “natural” doesn't automatically mean “safe” or “effective.” If you've ever wondered what's legit, what's hype, and what's just expensive placebo, this episode will make you feel so much smarter.Sign up for our newsletter here!For weekly episodes, come join the Foodie Fam!Check out our book!Chat with us on IG @foodweneedtotalk!Be friends with Juna on Instagram and Tiktok! Learn about your ad choices: dovetail.prx.org/ad-choices

This episode is an interview with Dr. Wouter Vaes, the Chief Science Officer of Peregrion. We discuss how accelerator mass spectrometry is being used in early clinical development for drug metabolism and pharmacokinetics. We discuss using this technology to support development of oncology agents, determining absolute bioavailability without IV toxicology work, and more. Links discussed in the show:You can contact Wouter by email: wouter.vaes@peregrion.com Connect with Peregrion on LinkedIn or their websiteSymposium on microtracer studies FDA guidance on safety testing of drug metabolitesWhite paper on human ADME data You can connect with Nathan on LinkedIn and send me a message Send Nathan a message Sign up for Nathan's newsletter Copyright Teuscher Solutions LLCAll Rights Reserved

MOPs & MOEs is powered by TrainHeroic, the best coaching app on the planet. ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Click here to get 14 days FREE and a consult with the coaches at TrainHeroic to help you get your coaching business rolling on TrainHeroic. ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ MOPs & MOEs delivers our training through ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TrainHeroic and you can ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠get your first 7 days of training with us FREE by clicking here.⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠To continue the conversation, ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠join our Discord!⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ We have experts standing by to answer your questions.You asked for it, here it is: a peptides episode. These are the hotness lately, getting tons of business and media attention (and anecdotal reports from athletes). But we constantly hear that there is no human safety or effectiveness data. So what are well intentioned consumers to do? To answer that question we have Dr. Rachele Pojednic back on the pod, and she is uniquely suited to talk about this issue. Rachele is a renowned expert, researcher, international speaker and thought-leader in nutrition and exercise science. Her primary roles are Adjunct Lecturer at Stanford University and Chief Science Officer at RestoreLabs. We don't just look at the current science on peptides, we also dive into what structural challenges have prevented more research in this area. As it turns out, we may be in a moment where regulatory changes may create some big opportunities in the very near future.Rachele mentioned examine.com as a great resource for analysis and summaries on nutrition and supplement research.We also touched on a recent article in Task & Purpose where a Marine Corps lawyer claimed his client unknowingly took prohibited peptides thinking they were approved supplements.

Peptides have taken the health and wellness space by storm. Is it hype, or do they have significant health outcomes? Jim LaValle, a pioneer in the world of peptides, is here to break down why they're the future of medicine and how they can help you live a healthier, longer life. Jim has dedicated over 40 years to the science of health and wellness. As an expert in integrative and precision medicine, he has been at the forefront of peptide therapy for 15 years. He's seen firsthand how peptides can help people regain their vitality, whether recovering from an injury, battling hormonal imbalances, or even combating metabolic disorders.  In this episode, Jim and I explore the fascinating world of peptides and how they're being used to enhance everything from weight loss to improved sleep. You'll discover which peptides you should consider, how they work in your body, and why they're the next frontier in preventive healthcare.  "The advantage of peptides is that they're signaling molecules that our bodies are already familiar with. So it's a gentler way of correcting problems that you may have."  ~ Jim LaValle In This Episode: - Meet Jim LaValle - History and basics of peptides - Finding the right peptides and providers - Popular peptides and their benefits - The best peptides for overall wellbeing - Future of peptides and potential side effects - MIORA: Personalized peptides & lifestyle programs - Jim La Valle's daily routine for optimal health - Episode wrap-up and Jim's message to the world About Jim LaValle: Jim LaValle, RPh, CCN, is a clinical pharmacist, board-certified nutritionist, and author with 40+ years of experience. He specializes in precision and performance health, integrating metabolic-based care. Founder of Metabolic Code Enterprises, he has taught at institutions like the University of Cincinnati and George Washington School of Medicine. LaValle has worked with elite sports teams, the military, and first responders to optimize their performance and recovery. He has authored 26 books, including Cracking the Metabolic Code, and over 200 articles. Currently, he serves as Chief Science Officer at Life Time, leading scientific initiatives for its longevity and performance program, MIORA. Instagram: https://www.instagram.com/therealjimlavalle/   Facebook: https://www.facebook.com/people/Jim-LaValle/100062990514032/   Website: https://www.jimlavalle.com/  Where to find me: IG: https://www.instagram.com/jen_gottlieb/    TikTok: https://www.tiktok.com/@jen_gottlieb     Facebook: https://www.facebook.com/Jenleahgottlieb    Website: https://jengottlieb.com/    My business: https://www.superconnectormedia.com/     YouTube: https://www.youtube.com/@jen_gottlieb

The backlash against Dr. Peter Attia has been swift and unforgiving since newly released documents from the Jeffrey Epstein files revealed an extensive and friendly correspondence between the celebrity longevity doctor and the convicted sex offender — including over 1,700 mentions of Attia in the trove — complete with casual and crude exchanges that reflected an ongoing relationship well after Epstein's 2008 conviction. Attia's name popping up repeatedly in the federal materials has shocked many of his followers and critics alike, not least because he built his public brand on health, integrity, and longevity advice while quietly maintaining a social rapport with someone now widely understood as a deeply exploitative predator. One especially unsettling detail — emails joking about sex and lifestyle — has made even the most technical defense of his interactions ring hollow for critics who see this not as harmless professional contact but as an elitist embrace of a man whose abuses were known to the world.The blowback hasn't been abstract — it's already cost Attia real-world roles and credibility. He resigned from his position as Chief Science Officer at David Protein and has been forced to apologize publicly, calling the emails “embarrassing, tasteless, and indefensible,” while CBS News reportedly weighs cutting ties with him as a contributor amid internal and public pressure to dissociate from his tarnished judgment. Many observers have labeled his apology as insufficiently contrite and criticized him for not addressing the deeper ethical implications of befriending a convicted child trafficker, arguing that his reputation as a trusted health authority is fundamentally shaken. Rather than confronting how his willingness to hobnob with Epstein reflects on his values and professional integrity, Attia's defensive framing — insisting he wasn't involved in criminal activity and emphasizing that he wouldn't act that way “today” — has been seen by some as tone-deaf and self-protective, feeding into narratives about elites dodging accountability.to contact me:bobbycapucci@protonmail.comsource:Dr. Peter Attia, longevity expert, apologizes for "indefensible" emails to Jeffrey Epstein - CBS News

Aging does NOT have to keep us down. In this episode, join me for a feel-good conversation with the CSO of Berkeley Life– Cathy Eason– all about midlife, hormones, and protecting your heart as you age stronger.  Together, we explore how boosting mitochondrial health and blood flow can radically improve energy, resilience, and overall vitality.  Kathy shares actionable lifestyle strategies to increase nitric oxide production for easing symptoms, plus offers supportive solutions when you need a little extra help during perimenopause and menopause.  We also talk about targeted supplements that support heart health, circulation, mood, sleep, stress response, and neurotransmitters—all in one place.  Tune in here to boost your blood flow, help your heart, and thrive through midlife and beyond!Cathy Eason Cathy Eason is the Chief Science Officer at Berkeley Life. She has over 20 years of experience as a functional medicine focused nutritionist, women's health educator, speaker, and wellness strategist specializing in midlife health. She bridges cutting-edge science with practical solutions for perimenopause and menopause, focusing on cardiovascular health, nitric oxide biochemistry, and whole-body resilience. Cathy's known for translating complex physiology into empowering insights that help women thrive through midlife and beyond. IN THIS EPISODE Cathy's perimenopause journey & her non-negotiables for thriving through it  The benefits of regulating your nervous system How insulin resistance impacts perimenopause symptoms  Why we need to talk more about blood flow for whole body wellness  The benefit of nitric oxide in perimenopause and menopause  How to best support yourself through midlife hormone shifts  The positive impact of Berkeley Life supplementation  How to get 15% off your Berkeley Life Nitric Oxide supplement!  QUOTES“We're seeing those perimenopausal signs come on earlier and earlier, and unfortunately, I think it's happening to younger and younger women too.” “We need to stop apologizing for what's happening to us. Recognize that we can be proactive about our health, but we also don't have to apologize for sweating during a meeting, or being a little cranky in the morning because we didn't get good sleep the night before.” “That's the biggest thing I feel by taking the Berkeley Life supplementation— I have consistent energy every day and I wake up motivated for the day ahead of me. And to me that equates to being energized, to having mitochondrial energy to get me through the day.” RESOURCES MENTIONED Order my new book: The Perimenopause Revolution https://peri-revolution.com/ Order your Berkeley Life Nitric Oxide Support Supplement HERE! https://berkeleylife.pxf.io/Vxvdja Use Code: THRIVE15 for 15% off! Berkeley Life Website Berkeley Life on Instagram Berkeley Life on Facebook Berkeley Life LinkedIn Berkeley Life on YouTube RELATED EPISODES  675: Feeling Off After 40? The Surprising Vitality Molecule to Reignite Your Energy, Libido & Confidence with Cathy Eason 711: Estrogen, Inflammation, and Your Heart Health: What Every Woman Needs to Know with Dr. Sanjay Bhojraj 704: Hormone Intelligence for Women in Midlife: How to Thrive Through Perimenopause with Dr. Aviva Romm 693: Tired All the Time? It Might Be Hidden Problems With Your Mitochondria with Siobhan Mitchell

World leaders in Davos are talking about 'tech sovereignty', but can Europe or the UK really achieve digital autonomy when so much of the AI and cloud infrastructure is controlled by a handful of US firms? Danny and Katie talk to Hany Farid about the geopolitics of tech, and the fear of an 'AI kill switch' - is this scaremongering or a real concern?Guest: Hany Farid, UC Berkeley professor and Co‑Founder & Chief Science Officer at GetReal Security.Image: Getty Hosted on Acast. See acast.com/privacy for more information.